Quantbot Technologies LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $1,100 - $1,429	-10 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $997 - $1,484	10 New	10 $1,000
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $113,916 - $163,131	-1,778 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $115,694 - $174,670	1,778 New	1,778 $152,000
Q4 2019 Feb 10, 2020	SELL	$40.86 - $57.65 $18,387 - $25,942	-450 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $5,607 - $7,420	-150 Reduced 25.0%	450 $18,000
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $23,874 - $40,206	600 New	600 $26,000
Q4 2018 Feb 13, 2019	SELL	$29.75 - $42.9 $61,463 - $88,631	-2,066 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$32.79 - $43.0 $1,573 - $2,064	-48 Reduced 2.27%	2,066 $77,000
Q2 2018 Aug 13, 2018	BUY	$23.62 - $42.29 $49,932 - $89,401	2,114 New	2,114 $83,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.